Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment
Ashenafi Tazebew Amare, Director General of Ethiopian Blood and Tissue Bank Service, shared a post on LinkedIn:
“A Year of Progress, Transformation and Renewed Commitment
Yesterday, we held our Annual Staff Meeting of the Ethiopian Blood and Tissue Bank Service (EBTBS) to review our performance, reflect on challenges, and align on the reform agenda and priorities for the coming fiscal year.
The year brought significant milestones:
- 476,000+ units of blood collected (a 12% increase from last year) and 570+ corneas collected.
- 7 new blood banks and one eye bank added, expanding access across the country.
- Automated testing centers increased from 7 to 12, alongside the introduction of a NAT platform.
- 100 freezers distributed, with new cold and freezing rooms established at three high-performing regional centers and the national center.
- Apheresis and REVEOS automated component processing introduced—major steps forward in efficiency, quality and innovation.
- Preparations for Level 3 accreditation and the stem cell processing laboratory are well underway.
- Digital transformation emerged as one of the defining achievements of the year.
We are working on legislation, policy, and training to advance the transition toward coordinating organ donation and transplantation, in addition to the existing mandates for blood, tissue, and cellular therapy services.
These achievements were made despite significant challenges, including human-resource shortages, financial constraints, supply-chain unpredictability, and logistics gaps.
Looking ahead, our reform agenda will place strong emphasis on competency assessment, workforce development, and continuous improvement.
The message is simple: we must not only expand our services – we must build the capabilities, systems, and people required to sustain excellence.
Grateful to our dedicated staff, blood donors, Federal Ministry of Health Ethiopia, partners, and stakeholders who continue to make this transformation possible.
The journey continues. Together, we are building the future of blood, tissue, organ and cellular therapy services in Ethiopia.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment